2014 News

2013 News

2012 News

2011 News

2010 News









Association for Molecular Pathology

AMP Archived News - 2014

AMP 2014 Annual Meeting Wraps-up with Record Level Attendance

December 11, 2014: More than 1,900 attendees plus nearly as many exhibitors gathered for the AMP 2014 Annual Meeting. Highlights included an address by Francis Collins, a conversation with the FDA, and AMP's first ever Advocacy Day. Thanks to everyone who participated for making the meeting a success!

View the Press Release.


AMP Partners with AMA and others on Letter to the FDA re: Regulation of LDTs

November 18, 2014: AMP joined the AMA and numerous other organizations in writing a letter to the FDA asking them to withdrawal the proposed draft guidance which seeks to regulate laboratory developed tests (LDTs). The letter urges the FDA to engage in the notice and comment rulemaking process as required under the Administrative Procedures Act (APA).

View the co-signed Letter.


AMP Announces Award Winners

November 14, 2014: Uta Francke, MD was awarded the AMP Award for Excellence in Molecular Diagnostics; Aaron Bossler, MD, PhD received the AMP Meritorious Service Award, and Elaine Lyon, PhD, was presented with the Jeffrey A. Kant Leadership Award.

View the Press Release


AMP Establishes Informatics Subdivision!

November 13, 2014: AMP President, Elaine Lyon, PhD, announced the formation of the Informatics Subdivision. The groundswell of interest by AMP members clearly identified the need for a subdivision of the Association dedicated to informatics. .

View the Press Release


AMPlifications - November 2014 Issue

In this pre-Annual Meeing issue, check out highlights of the meeting as well as a snapshot of AMP's initiatives in the realms of education, advocacy, innovation & improved patient care.

View the Newsletter


AMP Adds Late-Breaking Session on LDPs Oversight and Regulation

October 23, 2014: The late-breaking session, titled, "Framework for Oversight of LDTs: A Conversation with FDA" is scheduled for Thursday, November 13, 2014 at 1:00pm EST. Immediately following, AMP will host a press conference, convening a panel of molecular pathology clinical professionals, from a variety of clinical laboratory settings, to appropriately frame the discussion regarding clinical care and appropriate regulation.

View the Press Release

View the Annual Meeting Program


AMP Statement Regarding Proposed Rule

September 30, 2014: The Draft Guidance released today is almost identical to the Anticipated Details of the Draft Guidance of the Framework for Oversight of LDTs released on July 31. AMP continues to have deep concerns about the Framework itself and possible FDA regulation of laboratory developed procedures more generally. We look forward to conversations with the FDA during a special session at the AMP Annual Meeting next month.


AMP Submits Testimony to U.S. House regarding Regulation of LDPs

September 2014: In a letter to the U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health, AMP reaffirmed its position that an extensive new regulatory scheme such as that proposed by FDA poses an enormous threat to future diagnostic development, and to the health and well-being of patients.

View the Testimony


AMP Comments on 2015 Physician Fee Schedule Proposed Rule

September 2014: In a letter to CMS, AMP expressed concern over revisions to Part B Proposed Rule for CY 2015, focusing on five specific areas of importance to AMP members.

View the Comments


AMP Opposes Federal Employee Travel Restrictions in S 1347

July/August 2014: AMP sent a letter and and co-signed a letter with 123 other organizations opposing S 1347. This legislation would place harmful restrictions on medical and scientific meetings that would threaten scientific progress and the ability of federal employee physicians to get essential continuing medical education.

View AMP's Letter

View the co-signed Letter


AMP Addresses USPTO in Letter Endorsed by ASCP and BCA

July 2014: AMP urged the USPTO to make it clear that applications that attempt to claim the associations between genetic changes and physical characteristics or physiological effects, whether through process claims that in effect claim these natural relationships, or through claims on the gene sequences themselves, are directed toward patent ineligible subject matter.

View the Comments


AMP Voices Concern with FDA Anticipated Details of Laboratory Developed Test Draft Guidance

July 2014: AMP reaffirms its position that the current CLIA program at the Centers for Medicare & Medicaid Services (CMS) provides appropriate oversight for LDTs.

View the Press Release


AMP 2013 Annual Report Now Available

The first-ever annual report includes membership statistics, milestone & achievements, and a financial review of the Association.

View the Report


AMP Election Results

AMP Past President, Jennifer Hunt, MD, MEd, announced last week the newly elected leadership for AMP. We thank them for their upcoming service and thank all of you for voting!

View the list of newly elected AMP leadership


AMP Provides Comments Regarding the 21st Century Cures Initiative

June 2014: In a letter to Chairman Fred Upton and Representative Diana DeGette, AMP encouraged Congress to work to remove regulatory and reimbursement hurdles harming the diagnostic industry.

View the Comments


AMP Expresses Concerns about Product Labeling in Letter to the FDA

May 2014: In a letter to Dr. Jeffrey Shuren, AMP expressed concerns over FDA's inclusion of medical practice recommendations in product labeling for in vitro diagnostic tests.

View the Comments


Francis S. Collins to Speak at AMP 2014 Annual Meeting

April 2014: "We are incredibly honored to have Dr. Collins with us," said Elaine Lyon, MD, PhD, AMP President," he pioneered the field of genomics and continues to help create the landscape for precision medicine and the work of AMP members."

View the Press Release


AMP Publishes Curriculum Recommendations for Medical Laboratory Scientists

April 2014: Report in the May issue of JMD provides recommendations for both the baccalaureate and master's levels of education. "As the organization that is home to all molecular diagnostic professionals, AMP has a responsibility to help guide the training for future molecular technologists," said Elaine Lyon, PhD, AMP President.

View the Press Release


AMP Celebrates the Contributions of Medical Laboratory Professionals during Lab Week 2014

April 2014: "We are pleased to join ASCP in recognizing the tremendous contributions of laboratory professionals whose specialized training and expertise are essential to the interpretation of test results, which enable patients and their physicians to make more informed treatment and care decisions," said AMP President Elaine Lyon, PhD.

View the Press Release


AMP Mourns the Loss of Raymond R. Tubbs, DO

Dr. Raymond R. Tubbs, a good friend and colleague of many AMP members, passed away early Saturday morning, April 19, 2014. Ray joined AMP in April 1995 and was a member of the Strategic Planning Committee. Continued..

View the Obituary


AMP Concerned over Proposed Changes to CLFS Payment Policy

March 2014: AMP outlines significant concerns regarding sweeping changes to the Clinical Laboratory Fee Schedule (CLFS) in SGR patch legislation, submits letter to House Majority Leader.

Read the letter to Sen Harry Reid